August, 2023

article thumbnail

Pharmacy Staffing Shortages Lead to Disruptions in Patient Care

Drug Topics

A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.

article thumbnail

Rise of Third-Party Pharmacy Audits

Drug Topics

A greater number of pharmacy audits are originating not only from third party payors, but also from various government agencies, such as Medicare and Medicaid.

187
187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opioid Settlement May Spur Cannabis as Potential New Pharmacy Revenue Stream

Pharmacy Times

The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.

169
169
article thumbnail

STAT+: One dose of psilocybin may have lasting effects on major depression, study finds

STAT

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association. Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Amid shortage, FDA clears several generics of Takeda's popular ADHD drug Vyvanse

Fierce Pharma

After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.

FDA 138
article thumbnail

Info blocking enforcement for health IT entities begins Sept. 1, brings fines of up to $1M per violation

Fierce Healthcare

Enforcement of information blocking penalties for health IT entities is slated to go into effect on Friday, opening the door to penalties of up to $1 million per violation. | The Department of Health and Human Services Office of Inspector General said it expects to receive more complaints than it can investigate and so will be prioritizing those meeting certain criteria.

135
135

More Trending

article thumbnail

Don’t Get Caught Up With a HIPAA Violation

Drug Topics

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

HIPAA 200
article thumbnail

Revolutionizing Drug Development Through Artificial Intelligence, Machine Learning

Pharmacy Times

The seamless integration of artificial intelligence and machine learning has the potential to accelerate research and enhance efficiency in a new era of personalized medicine.

169
169
article thumbnail

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

STAT

WOODBURY, Minn. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages. The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. Teske told her boss at the vascular clinic where she worked that she was pregnant, and he asked if she wanted to sneak a look using the clinic’s ultrasound.

article thumbnail

Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower

Fierce Pharma

Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond the separation of its consumer health unit—Chief Financial Officer Joe Wolk described the compan | Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond separation of its consumer health unit—Chief Financial Officer Joe Wolk described the company’s appetite for M&A as “voracious.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Humana launches in-home primary care through CenterWell

Fierce Healthcare

Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.

134
134
article thumbnail

Watch DSN: The Compliance Team touches on clinical services’ effect on pharmacy space

Drug Store News

At NACDS’ Total Store Expo, DSN caught up with The Compliance Team’s founder and CEO to discuss how clinical services are changing the retail pharmacy space.

116
116
article thumbnail

Why Should Independent Pharmacies Stock Pet Medications?

Drug Topics

Caring for pets is easier when a pharmacist is involved.

article thumbnail

FDA Approves 0.9% Sodium Chloride Injection in 10, 20 mL Single-Dose Vials

Pharmacy Times

Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.

FDA 149
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Medicaid rebukes states for mistakenly disenrolling children

STAT

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.

Insurance 144
article thumbnail

FDA turns down Outlook's ophthalmic version of Roche's Avastin over manufacturing, data shortfalls

Fierce Pharma

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. | Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated version, but instead got a rejection letter.

FDA 126
article thumbnail

CMS suspects auto-renewal process at fault for wrongful Medicaid disenrollments

Fierce Healthcare

In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.

132
132
article thumbnail

Walmart kicks off Testing and Treatment Program at pharmacies in 12 states

Drug Store News

Under the program, Walmart pharmacists will test and treat customers for strep throat, flu and COVID-19.

112
112
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Filling Prescriptions for Pet Patients: Best Practices

Drug Topics

Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.

187
187
article thumbnail

Ferric Carboxymaltose Therapy Does Not Significantly Improve Heart Failure Mortality

Pharmacy Times

Ferric carboxymaltose was not found to have a significant impact on 6-minute walk distance, which is part of the primary outcome’s hierarchical composite of death and hospitalizations from heart failure.

Hospitals 145
article thumbnail

STAT+: Departing Stanford president retracts two widely cited papers, against lead author’s wishes

STAT

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne , the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

142
142
article thumbnail

Johnson & Johnson slashes price of tuberculosis drug Sirturo after relinquishing patent protections

Fierce Pharma

Seven weeks after saying it would allow generic competition for drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low- and middle-income countries (LMICs), Johnson & Johnson h | Seven weeks after saying it would allow generic competition for drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low- and middle-income countries (LMICs), Johnson & Johnson has slashed its own drug's price by 55% to $130 for a six-month course.

119
119
article thumbnail

Providers can now see patients' insurance coverage in GoodRx's cost comparison tool

Fierce Healthcare

GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.

article thumbnail

Stetson and Luke Grimes saddle up to reignite the brand for the modern age

Drug Store News

In our Q&A with Stephen Mormoris, CEO of Scent Beauty, he shares how teaming up with Yellowstone star Luke Grimes is helping the fragrance reach a younger audience.

111
111
article thumbnail

Cannabis Effective at Reducing Symptoms in Children With Cancer, but More Research Needed

Drug Topics

A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.

187
187
article thumbnail

Researchers Find Increased Risk of Atrial Fibrillation After Menopause

Pharmacy Times

Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.

132
132
article thumbnail

Opinion: It’s long past time for a more comprehensive Covid treatment approach

STAT

Because Covid cases and hospitalizations are no longer front-page news, many Americans might be surprised to learn that we are in the midst of a mini-surge. The latest data from the Centers for Disease Control and Prevention, from Aug. 12, confirm a 21.6% increase in Covid-19 hospitalizations from the prior week and a 21.4% increase in Covid-related deaths, demonstrating that Covid is not over and that Latinos and Blacks have reason to be concerned.

Hospitals 140
article thumbnail

Catalent passes baton to activist investor Elliott after 2023 earnings disappoint

Fierce Pharma

After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is handing the reins to activist investor Elliott Management. | After a tumultuous year of manufacturing hiccups, executive turnover and dwindling revenues, Catalent is linking up with Elliott Management. The CDMO giant struck a cooperation agreement with the activist investor group as it announced fourth-quarter revenues and unveiled a sweeping governance shakeup.

116
116
article thumbnail

How behavioral health app BeMe is aiming to connect with teens

Fierce Healthcare

In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.

130
130
article thumbnail

Stem cell therapy delivers potential for sickle cell disease

European Pharmaceutical Review

New research published in the New England Journal of Medicine has indicated that stem cell gene therapy could provide a curative treatment for sickle cell disease (SCD). Based on new data from the Novartis Phase I/II clinical trial , which used the first therapy to target a new genetic area and use cryopreserved stem cells, trial participants reported a decrease in vaso-occlusive events.

Hospitals 111
article thumbnail

FDA Delays Drug Supply Chain Security Act Deadline Until November 2024

Drug Topics

The new deadline to be in compliance with the requirements will be November 27, 2024.

FDA 187
article thumbnail

Upcoming Phase 3 Clinical Program Will Examine Efficacy of Oral PCSK9 Inhibitor MK-0616 in Patients With Hypercholesterolemia

Pharmacy Times

The phase 3 clinical program, CORALreef, consists of 3 trials and is likely the first of its kind for an oral PCSK9 inhibitor, according to the study authors.

123
123
article thumbnail

STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

STAT

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process. The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.